Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Merck Cash on Hand 2010-2023 | MKGAF

Merck cash on hand from 2010 to 2023. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
  • Merck cash on hand for the quarter ending December 31, 2023 was $2.685B, a 17.18% increase year-over-year.
  • Merck cash on hand for 2023 was $2.685B, a 17.18% increase from 2022.
  • Merck cash on hand for 2022 was $2.292B, a 6.56% decline from 2021.
  • Merck cash on hand for 2021 was $2.453B, a 45.07% increase from 2020.
  
Merck Annual Cash on Hand
(Millions of US $)
2023 $2,685
2022 $2,292
2021 $2,453
2020 $1,691
2019 $939
2018 $2,591
2017 $767
2016 $1,200
2015 $1,175
2014 $6,750
2013 $4,505
2012 $3,251
2011 $2,862
2010 $
2009 $
Merck Quarterly Cash on Hand
(Millions of US $)
2023-12-31 $2,685
2023-09-30 $2,811
2023-06-30 $2,101
2023-03-31 $1,847
2022-12-31 $2,292
2022-09-30 $1,965
2022-06-30 $1,823
2022-03-31 $1,622
2021-12-31 $2,453
2021-09-30 $1,963
2021-06-30 $2,253
2021-03-31 $2,770
2020-12-31 $1,691
2020-09-30 $1,909
2020-06-30 $1,700
2020-03-31 $1,777
2019-12-31 $939
2019-09-30 $5,989
2019-06-30 $4,051
2019-03-31 $2,730
2018-12-31 $2,591
2018-09-30 $1,039
2018-06-30 $869
2018-03-31 $1,007
2017-12-31 $767
2017-09-30 $1,114
2017-06-30 $1,245
2017-03-31 $1,220
2016-12-31 $1,200
2016-09-30 $1,076
2016-06-30 $934
2016-03-31 $1,089
2015-12-31 $1,175
2015-09-30 $12,938
2015-06-30 $9,605
2015-03-31 $8,849
2014-12-31 $6,750
2014-09-30 $3,523
2014-06-30 $2,473
2014-03-31 $5,121
2013-12-31 $4,505
2013-09-30 $4,381
2013-06-30 $4,344
2013-03-31 $3,832
2012-12-31 $3,251
2012-09-30 $3,663
2012-06-30 $2,859
2012-03-31
2011-12-31 $2,862
2011-09-30
2011-06-30 $2,471
2011-03-31
2010-12-31
2010-09-30 $1,913
2010-06-30
2010-03-31
2009-12-31
2009-09-30
2009-06-30
2009-03-31
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $23.587B $22.719B
Merck is a global pharmaceutical and chemical company. Its success is characterized by innovations from entrepreneurial employees. Merck's operating activities come under the umbrella of Merck KGaA, in which the Merck family holds an approximately 70% interest and free shareholders own the remaining approximately 30%. In 1917 the U.S. subsidiary Merck & Co. was expropriated and has been an independent company ever since.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $79.263B 32.23
Chugai Pharmaceutical (CHGCY) Japan $51.982B 23.24
Takeda Pharmaceutical (TAK) Japan $42.124B 8.53
Astellas Pharma (ALPMY) Japan $17.518B 27.66
Sandoz Group AG (SDZNY) Switzerland $15.512B 0.00
Neurocrine Biosciences (NBIX) United States $14.281B 39.09
Shionogi (SGIOY) Japan $13.629B 11.85
United Therapeutics (UTHR) United States $12.075B 12.87
Catalent (CTLT) United States $9.999B 0.00
Cerevel Therapeutics Holdings (CERE) United States $7.716B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $6.965B 7.66
Revolution Medicines (RVMD) United States $6.433B 0.00
Orion OYJ (ORINY) Finland $5.645B 23.81
Ionis Pharmaceuticals (IONS) United States $5.491B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.396B 0.00
Madrigal Pharmaceuticals (MDGL) United States $4.628B 0.00
Alpine Immune Sciences (ALPN) United States $4.456B 0.00
Crinetics Pharmaceuticals (CRNX) United States $4.094B 0.00
Summit Therapeutics (SMMT) United States $3.166B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $3.105B 0.00
Corcept Therapeutics (CORT) United States $2.867B 25.98
PTC Therapeutics (PTCT) United States $2.610B 0.00
Dyne Therapeutics (DYN) United States $2.512B 0.00
Indivior (INDV) United States $2.391B 11.33
Recursion Pharmaceuticals (RXRX) United States $2.232B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.083B 11.84
Evotec AG (EVO) Germany $1.946B 0.00
Catalyst Pharmaceuticals (CPRX) United States $1.937B 18.85
Fusion Pharmaceuticals (FUSN) Canada $1.825B 0.00
Ardelyx (ARDX) United States $1.813B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $1.804B 0.00
Taro Pharmaceutical Industries (TARO) Israel $1.586B 27.76
Avadel Pharmaceuticals (AVDL) Ireland $1.532B 0.00
Soleno Therapeutics (SLNO) United States $1.526B 0.00
Pacira BioSciences (PCRX) United States $1.467B 13.94
Xencor (XNCR) United States $1.385B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.335B 0.00
4D Molecular Therapeutics (FDMT) United States $1.326B 0.00
Cronos Group (CRON) Canada $1.154B 0.00
Enliven Therapeutics (ELVN) United States $1.120B 0.00
Collegium Pharmaceutical (COLL) United States $1.102B 6.59
Ironwood Pharmaceuticals (IRWD) United States $1.039B 16.19
Cassava Sciences (SAVA) United States $1.034B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.012B 0.00
Ocular Therapeutix (OCUL) United States $0.971B 0.00
USANA Health Sciences (USNA) United States $0.924B 15.11
ARS Pharmaceuticals (SPRY) United States $0.882B 0.00
ProKidney (PROK) United States $0.869B 0.00
Relay Therapeutics (RLAY) United States $0.864B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.823B 0.00
Sage Therapeutics (SAGE) United States $0.723B 0.00
Lyell Immunopharma (LYEL) United States $0.709B 0.00
Silence Therapeutics (SLN) United Kingdom $0.687B 0.00
Calliditas Therapeutics AB (CALT) Sweden $0.656B 0.00
Savara (SVRA) United States $0.652B 0.00
Altimmune (ALT) United States $0.631B 0.00
Exscientia (EXAI) United Kingdom $0.620B 0.00
Harrow (HROW) United States $0.572B 0.00
Siga Technologies (SIGA) United States $0.562B 7.18
Verve Therapeutics (VERV) United States $0.536B 0.00
OmniAb (OABI) United States $0.533B 0.00
Bioventus (BVS) United States $0.525B 20.09
KalVista Pharmaceuticals (KALV) United States $0.509B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.491B 0.00
Esperion Therapeutics (ESPR) United States $0.491B 0.00
Heron Therapeutics (HRTX) United States $0.485B 0.00
Korro Bio (KRRO) United States $0.475B 0.00
Larimar Therapeutics (LRMR) United States $0.474B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.467B 0.00
Lexeo Therapeutics (LXEO) United States $0.462B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.388B 0.00
Tourmaline Bio (TRML) United States $0.385B 0.00
Organogenesis (ORGO) United States $0.378B 71.25
Nanobiotix S.A (NBTX) France $0.342B 0.00
Nektar Therapeutics (NKTR) United States $0.331B 0.00
Fractyl Health (GUTS) United States $0.320B 0.00
Xeris Biopharma Holdings (XERS) United States $0.299B 0.00
Aquestive Therapeutics (AQST) United States $0.299B 0.00
Black Diamond Therapeutics (BDTX) United States $0.295B 0.00
Nature's Sunshine Products (NATR) United States $0.292B 18.58
ESSA Pharma (EPIX) Canada $0.277B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.277B 0.00
Metagenomi (MGX) United States $0.262B 0.00
Foghorn Therapeutics (FHTX) United States $0.247B 0.00
Pyxis Oncology (PYXS) United States $0.246B 0.00
Aldeyra Therapeutics (ALDX) United States $0.243B 0.00
Akebia Therapeutics (AKBA) United States $0.239B 0.00
Eliem Therapeutics (ELYM) United States $0.238B 0.00
Prelude Therapeutics (PRLD) United States $0.235B 0.00
Conduit Pharmaceuticals (CDT) United States $0.217B 0.00
Profound Medical (PROF) Canada $0.207B 0.00
Avita Medical (RCEL) United States $0.204B 0.00
Century Therapeutics (IPSC) United States $0.203B 0.00
Zevra Therapeutics (ZVRA) United States $0.199B 0.00
Galectin Therapeutics (GALT) United States $0.195B 0.00
Adherex Technologies (FENC) United States $0.195B 237.33
Acrivon Therapeutics (ACRV) United States $0.194B 0.00
Telomir Pharmaceuticals (TELO) United States $0.183B 0.00
VAXART, INC (VXRT) United States $0.180B 0.00
CytoDyn (CYDY) United States $0.178B 0.00
Incannex Healthcare (IXHL) Australia $0.176B 0.00
Innate Pharma SA (IPHYF) France $0.176B 0.00
Achieve Life Sciences (ACHV) Canada $0.174B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.172B 0.00
MediWound (MDWD) Israel $0.164B 0.00
Cardiol Therapeutics (CRDL) Canada $0.161B 0.00
Elite Pharmaceuticals (ELTP) United States $0.148B 13.90
OptiNose (OPTN) United States $0.146B 0.00
Context Therapeutics (CNTX) United States $0.135B 0.00
Karyopharm Therapeutics (KPTI) United States $0.134B 0.00
Regulus Therapeutics (RGLS) United States $0.131B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.124B 8.32
FibroGen (FGEN) United States $0.123B 0.00
Citius Pharmaceuticals (CTXR) United States $0.121B 0.00
PMV Pharmaceuticals (PMVP) United States $0.111B 0.00
Vivani Medical (VANI) United States $0.108B 0.00
Relmada Therapeutics (RLMD) United States $0.105B 0.00
ProPhase Labs (PRPH) United States $0.097B 0.00
Assertio Holdings (ASRT) United States $0.097B 4.43
SCYNEXIS (SCYX) United States $0.091B 1.28
AlloVir (ALVR) United States $0.086B 0.00
ARYA Sciences Acquisition Corp IV (ARYD) United States $0.086B 0.00
Aclaris Therapeutics (ACRS) United States $0.084B 0.00
Jaguar Animal Health (JAGX) United States $0.079B 0.00
Protara Therapeutics (TARA) United States $0.077B 0.00
Journey Medical (DERM) United States $0.072B 0.00
Tempest Therapeutics (TPST) United States $0.072B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.071B 0.00
Mural Oncology (MURA) Ireland $0.066B 0.00
Champions Oncology (CSBR) United States $0.064B 0.00
Carisma Therapeutics (CARM) United States $0.057B 0.00
Inotiv (NOTV) United States $0.056B 0.00
Reneo Pharmaceuticals (RPHM) United States $0.055B 0.00
Nutriband (NTRB) United States $0.052B 0.00
BioLineRx (BLRX) Israel $0.051B 0.00
Gain Therapeutics (GANX) United States $0.049B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.048B 0.00
ElectroCore (ECOR) United States $0.044B 0.00
CASI Pharmaceuticals (CASI) China $0.043B 0.00
Natural Alternatives (NAII) United States $0.042B 0.00
VYNE Therapeutics (VYNE) United States $0.039B 0.00
Rafael Holdings (RFL) United States $0.039B 0.00
Unicycive Therapeutics (UNCY) United States $0.039B 0.00
NRx Pharmaceuticals (NRXP) United States $0.038B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.037B 0.00
Surrozen (SRZN) United States $0.032B 0.00
Viracta Therapeutics (VIRX) United States $0.032B 0.00
JanOne (JAN) United States $0.031B 0.00
Lipocine (LPCN) United States $0.031B 0.00
DURECT (DRRX) United States $0.029B 0.00
Aptorum Group (APM) United Kingdom $0.026B 0.00
Oncternal Therapeutics (ONCT) United States $0.026B 0.00
Enlivex Therapeutics (ENLV) Israel $0.026B 0.00
Iterum Therapeutics (ITRM) Ireland $0.025B 0.00
TherapeuticsMD (TXMD) United States $0.024B 0.00
Lyra Therapeutics (LYRA) United States $0.022B 0.00
PolyPid (PYPD) Israel $0.021B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.021B 0.00
Indaptus Therapeutics (INDP) United States $0.020B 0.00
BioVie (BIVI) United States $0.020B 0.00
Talphera (TLPH) United States $0.020B 0.00
Alaunos Therapeutics (TCRT) United States $0.020B 0.00
MEI Pharma (MEIP) United States $0.020B 0.75
GlycoMimetics (GLYC) United States $0.018B 0.00
Minerva Neurosciences (NERV) United States $0.018B 0.00
Nuvilex (PMCB) United States $0.018B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.017B 0.00
CERo Therapeutics Holdings (CERO) United States $0.017B 0.00
Traws Pharma (TRAW) United States $0.016B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.015B 0.00
Mannatech (MTEX) United States $0.015B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.014B 0.00
Redhill Biopharma (RDHL) Israel $0.014B 0.00
Plus Therapeutics (PSTV) United States $0.013B 0.00
Dominari Holdings (DOMH) United States $0.012B 0.00
Cosmos Health (COSM) Greece $0.012B 0.00
Inhibikase Therapeutics (IKT) United States $0.011B 0.00
Biomerica (BMRA) United States $0.010B 0.00
Avalo Therapeutics (AVTX) United States $0.010B 0.00
Molecular Templates (MTEM) United States $0.010B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Universe Pharmaceuticals INC (UPC) China $0.009B 0.00
Vivos Therapeutics (VVOS) United States $0.007B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.007B 0.00
Ainos (AIMD) United States $0.007B 0.00
TransCode Therapeutics (RNAZ) United States $0.006B 0.00
Heatwurx (PCSA) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
Mangoceuticals (MGRX) United States $0.005B 0.00
Clever Leaves Holdings (CLVR) Canada $0.005B 0.00
SHINECO (SISI) China $0.005B 0.00
MyMD Pharmaceuticals (MYMD) United States $0.005B 0.00
XORTX Therapeutics (XRTX) Canada $0.005B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.004B 0.00
Petros Pharmaceuticals (PTPI) United States $0.004B 0.00
Phio Pharmaceuticals (PHIO) United States $0.003B 0.00
Finch Therapeutics (FNCH) United States $0.003B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
Altamira Therapeutics (CYTO) Bermuda $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
Avenue Therapeutics (ATXI) United States $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
Qualigen Therapeutics (QLGN) United States $0.002B 0.00
InMed Pharmaceuticals (INM) Canada $0.002B 0.00
PainReform (PRFX) Israel $0.002B 0.00
Bio-Path Holdings (BPTH) United States $0.002B 0.00
SciSparc (SPRC) Israel $0.001B 0.00
China SXT Pharmaceuticals (SXTC) China $0.000B 0.00
Aditxt (ADTX) United States $0.000B 0.00
Qilian Holding Group (QLI) China $0.000B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 4.96
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 35.44